bpc 157 endogenic | Gastric Pentadecapeptide BPC-157 | 15mg Peptide Pen

For BPC-157 specifically, the FDA reported limited and short human studies, a lack of adequate studies for several commonly used routes of administration, potential immunogenicity concerns, possible liver and clotting signals in animal studies, and three adverse-event reports, while noting that a cause could not be established

BPC-157, ipamorelin, and sermorelin, to name a few, are purported to affect growth hormone release, promote muscle growth, and cut fat

Each box includes 5 ampoules

Injections could correct this deficiency, increase energy levels, improve metabolic rate, and potentially aid weight loss

It's mechanism-driven protocol design